News & Articles

New range for use in drug level monitoring assays and biosimilar development

Automation-ready flow cytometer enables biomarker discovery and phenotypic screening

Published in the peer-reviewed journal mAbs, the paper introduces complex-specific antibodies for pharmacokinetic analysis of biotherapeutics

Droplet digital PCR’s effectiveness in detecting minimal residual disease was highlighted by researchers at 60th ASH annual meeting & exposition

An evening of stimulating talks about the automated preparation and sorting of viable neurons from adult mouse brain for functional assays and single cell sequencing.

Life science research and clinical diagnostics provider launches anti-pembrolizumab and anti-nivolumab antibodies to monitor drug levels in cancer patients

StarBright Blue 520 Fluorescent Secondary Antibodies offer best sensitivity among fluorescent dye–labeled secondary antibodies that emit in the green channel

The immunoassay is the market’s first validated high-performance multiplex screening panel

New antibodies used to support research into the treatment of ulcerative colitis and Crohn’s disease

Bio-Rad’s lncRNA Workflow includes highly sensitive and specific qPCR arrays and individual assays to assess more than 23,000 human lncRNA targets, aiding in lncRNA discovery and validation across many research areas

Bio-Rad shares its expertise to help perfect fluorescence-based protein detection and quantitation

Collector Offers Flexibility and Capacity for Applications from Discovery to Scale Up

Dysbiosis success triggers further investment and development agreement for additional microbiome tests beyond GA-map™ dysbiosis Test

QXDx BCR-ABL %IS kit achieves highest sensitivity for detecting disease remission in patients with chronic myeloid leukemia